Asthma, Adverse and Allergic Reactions (ARADyAL) (Q3162166): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||||||||||||||
Property / budget | |||||||||||||||
| |||||||||||||||
Property / budget: 35,000.0 Euro / rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
| |||||||||||||||
Property / EU contribution: 17,500.0 Euro / rank | |||||||||||||||
Property / date of last update | |||||||||||||||
| |||||||||||||||
Property / date of last update: 12 June 2023 / rank | |||||||||||||||
Property / budget | |||||||||||||||
35,000.0 Euro
| |||||||||||||||
Property / budget: 35,000.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
19,057.5 Euro
| |||||||||||||||
Property / EU contribution: 19,057.5 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
54.45 percent
| |||||||||||||||
Property / co-financing rate: 54.45 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
20 December 2023
| |||||||||||||||
Property / date of last update: 20 December 2023 / rank | |||||||||||||||
Normal rank |
Revision as of 16:56, 20 December 2023
Project Q3162166 in Spain
Language | Label | Description | Also known as |
---|---|---|---|
English | Asthma, Adverse and Allergic Reactions (ARADyAL) |
Project Q3162166 in Spain |
Statements
19,057.5 Euro
0 references
35,000.0 Euro
0 references
54.45 percent
0 references
1 January 2017
0 references
31 March 2022
0 references
FUNDACION INVESTIGACION BIOMEDICA DEL HOSPITAL NIÑO JESUS
0 references
Asma, Reacciones Adversas y Alérgicas (ARADYAL) (Spanish)
0 references
Asthma, Adverse and Allergic Reactions (ARADyAL) (English)
12 October 2021
0 references
Asthme, réactions indésirables et allergiques (ARADyAL) (French)
4 December 2021
0 references
Asthma, Nebenwirkungen und Allergische Reaktionen (ARADyAL) (German)
9 December 2021
0 references
Astma, bijwerkingen en allergische reacties (ARADyAL) (Dutch)
17 December 2021
0 references
Άσθμα, ανεπιθύμητες και αλλεργικές αντιδράσεις (ARADyAL) (Greek)
18 August 2022
0 references
Astma, bivirkninger og allergifremkaldende reaktioner (ARADyAL) (Danish)
18 August 2022
0 references
Astma, haittavaikutukset ja allergiset reaktiot (ARADyAL) (Finnish)
18 August 2022
0 references
Ażżma, Reazzjonijiet Avversi u Allerġiċi (ARADyAL) (Maltese)
18 August 2022
0 references
Astma, nevēlamās un alerģiskās reakcijas (ARADyAL) (Latvian)
18 August 2022
0 references
Frithghníomhartha asma, frithghníomhartha ailléirgeacha agus frithghníomhartha ailléirgeacha (ARADyAL) (Irish)
18 August 2022
0 references
Asztma, mellékhatások és allergiás reakciók (ARADyAL) (Hungarian)
18 August 2022
0 references
Astma, nepageidaujamos ir alerginės reakcijos (ARADyAL) (Lithuanian)
18 August 2022
0 references
Astma, nuspojave i alergijske reakcije (ARADyAL) (Croatian)
18 August 2022
0 references
Astma, biverkningar och allergireaktioner (ARADyAL) (Swedish)
18 August 2022
0 references
Astm bronșic, reacții adverse și alergice (ARADyAL) (Romanian)
18 August 2022
0 references
Astma, neželene in alergijske reakcije (ARADyAL) (Slovenian)
18 August 2022
0 references
Astma, działania niepożądane i alergiczne (ARADyAL) (Polish)
18 August 2022
0 references
Madrid
0 references
20 December 2023
0 references
Identifiers
RD16_0006_0026
0 references